Treatments for rare diseases

Five Israeli bio-techs at Israel’s MIXiii-Biomed 2018 are developing new therapies for “orphan” (rare) genetic diseases. They include ART Bioscience (Duchenne’s), Eloxx (cystinosis), SpliSense (Cystic Fibrosis), NewStem (Fragile X Syndrome) and Minovia (mitochondrial diseases).

https://www.israel21c.org/5-israeli-startups-seeking-cures-for-rare-genetic-diseases/

https://www.artbioscience.com/

http://www.eloxxpharma.com/

http://www.integra-holdings.com/portfolio-items/splisense/

http://www.iati.co.il/company/3793/newstem

http://www.iati.co.il/company/3522/minovia-therapeutics

http://kenes-exhibitions.com/biomed/program/#day1

 

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *